cancer clinical trials in maywood, IL

Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Breast Cancer

S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Lung Cancer

Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Endometrial Cancer

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Lymphoma

Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Loyola University Medical Center
Maywood, Illinois 60153

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Breast Cancer

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Leukemia

S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Breast Cancer

Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers

Loyola University
Maywood, Illinois 60153

Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases

Stem Cell Transplantation in Individuals With Multiple Myeloma

Loyola University
Maywood, Illinois 60153

Multiple Myeloma

Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Metastatic Cancer, Prostate Cancer

Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer

Loyola University Medical Center
Maywood, Illinois 60153

Adenocarcinoma of the Colon, Stage III Colon Cancer

Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer

Loyola University Medical Centre
Maywood, Illinois 60153

Breast Cancer

Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Head and Neck Cancer

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Leukemia

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Brain Tumor, Central Nervous System Tumor

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

Loyola University Medical Center
Maywood, Illinois 60153

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation

Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (Paradigm Trial)

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Head and Neck Cancer

Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Leukemia

Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Brain and Central Nervous System Tumors

Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Breast Cancer

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Leukemia

Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Lymphoma

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Leukemia

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Lymphoma

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Lymphoma

Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Metastatic Cancer, Prostate Cancer

Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)

Loyola University Medical Center, Cardinal Bernardin Cancer Center
Maywood, Illinois 60153

Graft-Versus-Host Disease

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Loyola University Medical Center
Maywood, Illinois 60153

Adenocarcinoma of the Colon, Stage II Colon Cancer

S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Lymphoma

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Bladder Cancer

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Loyola University Medical Center
Maywood, Illinois 60153

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Head and Neck Cancer

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Kidney Cancer

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois 60153-5500

Prostate Cancer

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Loyola University Medical Center
Maywood, Illinois 60153

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Loyola University Medical Center
Maywood, Illinois 60153

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

Loyola University Medical Center
Maywood, Illinois 60153

Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer

TOMUS-Trial Of Mid-Urethral Slings

Loyola University Medical Center
Maywood, Illinois 60153

Urinary Incontinence

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Loyola University Medical Center
Maywood, Illinois 60153

Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer

Comparison of Rituxan Versus Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (ASCT)

Loyola University Medical Center
Maywood, Illinois 60153

Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin

Join the directory

Join the Community

Join the Directory